Drug Discovery & Pharmaceuticals

RSS

Exploring the Relationship Between Mass Spectrometry and Informatics

Mass spectrometry has always had a powerful synergy with computers. Computers have pushed mass spectrometry forward at key junctures in it’s history from data collection to instrument operation to data analysis.

From Bruker Life Sciences Mass Spectrometry 9 Sep 2020

New bio-active natural products with huge potential as drugs

Natural compounds continue to play a key role in drug development. Many clinically approved drugs are either unmodified natural products or their semi-synthetic derivatives.

8 Sep 2020

Moving towards a new age of personalized, cell-based interceptive medicine for Europe

Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare.

7 Sep 2020

Study shows how genetic data can be used to prioritize drug targets for complex diseases

An innovative genetic study of blood protein levels, led by researchers in the MRC Integrative Epidemiology Unit at the University of Bristol, has demonstrated how genetic data can be used to support drug target prioritisation by identifying the causal effects of proteins on diseases.

7 Sep 2020

Relation Therapeutics announces Project RE to identify COVID-19 therapeutic candidates

Relation Therapeutics, a drug development company driven by data science and machine learning, today announces Project RE, which will apply Relation Therapeutics’ and its partners’ technology to the identification of repurposed drug combinations as potential therapeutic candidates for COVID-19.

3 Sep 2020

Scientists aim to find cortisone alternatives with fewer side effects

Many people use cortisone of a regular basis. It is used for treating rheumatism, asthma, multiple sclerosis, or even COVID-19.

2 Sep 2020

Pharmaceutical researchers aim to create better CBD-like treatments

Cannabidiol (CBD) is an increasingly popular wellness trend. The compound, which occurs naturally in cannabis plants, is added to many products that claim to reduce anxiety, alleviate pain and more, without the intoxication of its cousin tetrahydrocannabinol (THC).

2 Sep 2020

Cannabis-impaired driving among topics to be addressed at forensic toxicology nonprofit’s first virtual event

The Society of Forensic Toxicologists will host SOFTember, its virtual event in lieu of its annual meeting, which would have celebrated its 50th anniversary.

1 Sep 2020

Thomas Jefferson University receives grant for the development of CoraVax

The Commonwealth of Pennsylvania has announced grants totaling $10M to 23 entities to develop effective COVID-19 vaccines, treatments and therapies.

28 Aug 2020

Bulky benchtops for fingerprinting drugs could be replaced with a tiny photonic chip

As new infectious diseases emerge and spread, one of the best shots against novel pathogens is finding new medicines or vaccines.

28 Aug 2020

SARS discovery boots search for COVID-19 drugs

An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.

27 Aug 2020

Dotmatics announces the launch of Bioregister 2020.1

Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the introduction of Bioregister 2020.1, the latest version of its web-based application for registering sequence-based, chemically modified and structure-less biological entities.

27 Aug 2020

Accidental discovery of new antibiotic proven effective after several experiments

It all happened by chance. It was a hot summer day nine years ago. Inside the laboratory, the team was working on cancer research. On the lab bench, various medications were being tested on cancer cells.

24 Aug 2020

The Native Antigen Company announces custom contract service to develop influenza A and B antigens

The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the introduction of its custom contract service to rapidly develop antigen panels for influenza A and B viruses.

21 Aug 2020

AI can expedite drug repurposing process for finding COVID-19 therapies, says GlobalData

Out of all the different approaches available to find new therapies to treat COVID-19, drug repurposing is one of the fastest and safest methods, as the drugs are already being used to treat other conditions therefore leading to fewer chances of adverse reactions.

21 Aug 2020

Cobra Biologics successfully produced master cell banks for CombiGene’s gene therapy

Cobra Biologics, part of the Cognate BioServices family, an international CDMO manufacturer of biological materials and pharmaceuticals, and CombiGene AB, the leading gene therapy company in the Nordic region, today announced that Cobra has successfully produced master cell banks for the three plasmids used as starting material for CombiGene’s gene therapy CG01.

21 Aug 2020

Drug Discovery & Pharmaceuticals

Exploring the Relationship Between Mass Spectrometry and Informatics

New bio-active natural products with huge potential as drugs

Moving towards a new age of personalized, cell-based interceptive medicine for Europe

Study shows how genetic data can be used to prioritize drug targets for complex diseases

Relation Therapeutics announces Project RE to identify COVID-19 therapeutic candidates

Scientists aim to find cortisone alternatives with fewer side effects

Pharmaceutical researchers aim to create better CBD-like treatments

Cannabis-impaired driving among topics to be addressed at forensic toxicology nonprofit’s first virtual event

Thomas Jefferson University receives grant for the development of CoraVax

Bulky benchtops for fingerprinting drugs could be replaced with a tiny photonic chip

SARS discovery boots search for COVID-19 drugs

Dotmatics announces the launch of Bioregister 2020.1

Accidental discovery of new antibiotic proven effective after several experiments

The Native Antigen Company announces custom contract service to develop influenza A and B antigens

AI can expedite drug repurposing process for finding COVID-19 therapies, says GlobalData

Cobra Biologics successfully produced master cell banks for CombiGene’s gene therapy

CUNY School of Medicine and TechnoVax announce COVID-19 vaccine breakthrough

CARE consortium launches to accelerate drug discovery and development for COVID-19

Biotechnological production of a natural antibiotic

Studying the Proteome and Human Diseases using Mass Spectrometry

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest Life Science News